张宇欣,赵攀果,陈福祥,张金霞

• 1:中国人民解放军南部战区总医院心血管内科
• 2:南方医科大学第一临床医学院
• 3:广州中医药大学研究生院

摘要(Abstract)：

近些年，随着计算流体动力学与人工智能的发展，基于冠状动脉造影的微循环阻力指数相关技术取得重要创新，实现了无创评估冠状动脉微循环功能障碍，克服了传统有创微循环阻力指数需压力导丝和腺苷的局限。此类技术在急性ST段抬高型心肌梗死、急性非ST段抬高型心肌梗死、慢性冠状动脉综合征患者中均表现出良好的诊断性能和预后价值。本文综述了基于冠状动脉造影的微循环阻力指数技术的重要演进过程及其在不同类型冠心病诊疗中的最新研究进展，旨在为该类技术在冠心病的诊疗领域提供参考依据。

关键词(KeyWords)： 冠心病;冠状动脉微循环障碍;微循环阻力指数;基于冠状动脉造影的微循环阻力指数

Abstract:

Keywords:

基金项目(Foundation): 广州市科技计划项目（2023B01J1011）

作者(Author): 张宇欣,赵攀果,陈福祥,张金霞

参考文献(References)：

• [1]Fearon WF, Balsam LB, Farouque HM, et al. Novel index for invasively assessing the coronary microcirculation[J]. Circulation, 2003, 107(25):3129-3132. DOI:10.1161/01.CIR.0000080700.98607.D1.
• [2]De Maria GL,Scarsini R,Shanmuganathan M,et al. Angiographyderived index of microcirculatory resistance as a novel,pressure-wire-free tool to assess coronary microcirculation in ST elevation myocardial infarction[J]. Int J Cardiovasc Imaging,2020, 36(8):1395-1406. DOI:10.1007/s10554-020-01831-7.
• [3]Scarsini R, Shanmuganathan M, Kotronias RA,e t a l. Angiography-derived index of microcirculatory resistance(IMRangio)as a novel pressure-wire-free tool to assess coronary microvascular dysfunction in acute coronary syndromes and stable coronary artery disease[J]. Int J Cardiovasc Imaging, 2021,37(6):1801-1813. DOI:10.1007/s10554-021-02254-8.
• [4]Fan Y, Fezzi S, Sun P, et al. In vivo validation of a novel computational approach to assess microcirculatory resistance based on a single angiographic view[J]. J Pers Med, 2022,12(11):1798. DOI:10.3390/jpm12111798.
• [5]Ai H, Feng Y, Gong Y, et al. Coronary angiography-derived index of microvascular resistance[J]. Front Physiol, 2020,11:605356. DOI:10.3389/fphys.2020.605356.
• [6]Jiang J, Li C, Hu Y, et al. A novel CFD-based computed index of microcirculatory resistance(IMR)derived from coronary angiography to assess coronary microcirculation[J].Comput Methods Programs Biomed, 2022, 221:106897.DOI:10.1016/j.cmpb.2022.106897.
• [7]Tu S, Westra J, Yang J, et al. Diagnostic accuracy of fast computational approaches to derive fractional fl ow reserve from diagnostic coronary angiography:the international multicenter FAVOR pilot study[J]. JACC Cardiovasc Interv, 2016, 9(19):2024-2035. DOI:10.1016/j.jcin.2016.07.013.
• [8]Galli M, Niccoli G, De Maria G, et al. Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction[J]. Nat Rev Cardiol, 2024, 21(5):283-298.DOI:10.1038/s41569-023-00953-4.
• [9]Fearon WF,Low AF,Yong AS,et al. Prognostic value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary intervention[J]. Circulation, 2013, 127(24):2436-2441. DOI:10.1161/CIRCULATIONAHA.112.000298.
• [10]Camici PG, d’Amati G, Rimoldi O. Coronary microvascular dysfunction:mechanisms and functional assessment[J].Nat Rev Cardiol, 2015, 12(1):48-62. DOI:10.1038/nrcardio.2014.160.
• [11]van Kranenburg M, Magro M, Thiele H, et al. Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients[J]. JACC Cardiovasc Imaging,2014, 7(9):930-939. DOI:10.1016/j.jcmg.2014.05.010.
• [12]D u a n Y , Yi n Q , Yang Y, et al. Integrating angio-IMR and CMR-assessed microvascular obstruction for improved risk stratification of STEMI patients[J]. Sci Rep, 2025, 15(1):5470. DOI:10.1038/s41598-025-88942-0.
• [13]Choi KH , Dai N , Li Y, et al. Functional coronary angiography-derived index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction[J].JACC Cardiovasc Interv, 2021, 14(15):1670-1684.DOI:10.1016/j.jcin.2021.05.027.
• [14]Kotronias RA,Terentes-Printzios D,Shanmuganathan M , et al. Long-term clinical outcomes in patients with an acute ST-segment-elevation myocardial infarction stratified by angiography-derived index of microcirculatory resistance[J].Front Cardiovasc Med, 2021, 8:717114. DOI:10.3389/fcvm.2021.717114.
• [15]Li M, Peng X, Zheng N, et al. Coronary microvascular function assessment using the coronary angiography-derived index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. Rev Cardiovasc Med, 2024, 25(2):69. DOI:10.31083/j.rcm2502069.
• [16]Lu G,Zhao L,Hui K,et al. Angiography-derived microcirculatory resistance in detecting microvascular obstruction and predicting heart failure after STEMI[J]. Circ Cardiovasc Imaging, 2025, 18(5):e017506. DOI:10.1161/CIRCIMAGING.124.017506.
• [17]Wang H, Wu Q, Yang L, et al. Application of AMR in evaluating microvascular dysfunction after ST-elevation myocardial infarction[J]. Clin Cardiol, 2024, 47(2):e24196. DOI:10.1002/clc.24196.
• [18]Liu J, Zhang Q, Liu Z, et al. Microvascular reperfusion of fi brinolysis followed by percutaneous coronary intervention versus primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction[J]. Quant Imaging Med Surg,2024, 14(1):765-776. DOI:10.21037/qims-23-666.
• [19]Candreva A , Gotschy AMD PhD , Stehli J ,et al. Microcirculatory resistance after primary percutaneous coronary intervention predicts residual myocardial damage and scar formation[J]. J Am Heart Assoc, 2025, 14(4):e036033. DOI:10.1161/JAHA.124.036033.
• [20]Hou C, Guo M, Ma Y, et al. The coronary angiographyderived index of microcirculatory resistance predicts left ventricular performance recovery in patients with ST-segment elevation myocardial infarction[J]. J Interv Cardiol, 2022,2022:9794919. DOI:10.1155/2022/9794919.
• [21]Zhang Y, Pu J, Niu T, et al. Prognostic value of coronary angiography-derived index of microcirculatory resistance in nonST-segment elevation myocardial infarction patients[J]. JACC Cardiovasc Interv, 2024, 17(16):1874-1886. DOI:10.1016/j.jcin.2024.04.048.
• [22]Vrints C, Andreotti F, Koskinas KC, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes[J]. Eur Heart J, 2024, 45(36):3415-3537. DOI:10.1093/eurheartj/ehae177.
• [23]Fan Y, Li C, Hu Y, et al. Angiography-based index of microcirculatory resistance(AccuIMR)for the assessment of microvascular dysfunction in acute coronary syndrome and chronic coronary syndrome[J]. Quant Imaging Med Surg,2023, 13(6):3556-3568. DOI:10.21037/qims-22-961.
• [24]Wang B, Gao Y, Zhao Y, et al. The spectrum of angiographyderived IMR according to morphological and physiological coronary stenosis in patients with suspected myocardial ischemia[J]. Clin Cardiol, 2023, 46(5):502-511. DOI:10.1002/clc.23999.
• [25]中华医学会心血管病学分会，中华心血管病杂志编辑委员会.缺血伴非阻塞性冠状动脉疾病诊断及管理中国专家共识[J].中华心血管病杂志，2022, 50(12):1148-1160. DOI:10.3760/cma.j.cn112148-20220908-00682.
• [26]Kunadian V, Chieff o A, Camici PG, et al. An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology&Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group[J]. Eur Heart J, 2020, 41(37):3504-3520.DOI:10.1093/eurheartj/ehaa503.
• [27]Huang D, Gong Y, Fan Y, et al. Coronary angiographyderived index for assessing microcirculatory resistance in patients with non-obstructed vessels:the FLASH IMR study[J]. Am Heart J, 2023, 263:56-63. DOI:10.1016/j.ahj.2023.03.016.
• [28]Wang J, Li C, Zhang M, et al. The performance o f angiography-derived index of microcirculatory resistance for ischemia in angina with non-obstructive coronary artery disease:Validated by wire-based IMR and SPECT-MPI[J]. Int J Cardiol, 2025, 431:133236. DOI:10.1016/j.ijcard.2025.133236.
• [29]Dai N, Che W, Liu L, et al. Diagnostic value of angiographyderived IMR for coronary microcirculation and its prognostic implication after PCI[J]. Front Cardiovasc Med, 2021, 8:735743. DOI:10.3389/fcvm.2021.735743.
• [30]Mohammed AA, Zhang H, Abdu FA, et al. Effect o f nonobstructive coronary stenosis on coronary microvascular dysfunction and long-term outcomes in patients with INOCA[J]. Clin Cardiol, 2023, 46(2):204-213. DOI:10.1002/clc.23962.
• [31]Leung M, Leung DY. Coronary microvascular function in patients with type 2 diabetes mellitus[J]. EuroIntervention,2016, 11(10):1111-1117. DOI:10.4244/EIJY15M03_09.
• [32]Wu Y, Liu J, Du X, et al. Prognostic value of angiographyderived index of microcirculatory resistance in patients with diabetes and ST-segment elevation myocardial infarction[J].Can J Cardiol, 2025, 41(10):2041-2051. DOI:10.1016/j.cjca.2025.05.001.
• [33]张启贤，高松原，方舒，等.基于冠状动脉造影的微循环阻力指数对冠心病患者PCI术后的预后价值[J].中华心血管病杂志，2025, 53(5):505-513. DOI:10.3760/cma.j.cn112148-20250123-00065.
• [34]Zhang W, Singh S, Liu L, et al. Prognostic value o f coronary microvascular dysfunction assessed by coronary angiography-derived index of microcirculatory resistance in diabetic patients with chronic coronary syndrome[J].Cardiovasc Diabetol, 2022, 21(1):222. DOI:10.1186/s12933-022-01653-y.
• [35]Carrick D, Haig C, Ahmed N, et al. Myocardial hemorrhage after acute reperfused ST-segment-elevation myocardial infarction:relation to microvascular obstruction and prognostic signifi cance[J]. Circ Cardiovasc Imaging, 2016, 9(1):e004148. DOI:10.1161/CIRCIMAGING.115.004148.
• [36]Taqueti VR, Di Carli MF. Coronary microvascular disease pathogenic mechanisms and therapeutic options:JACC state-ofthe-art review[J]. J Am Coll Cardiol, 2018, 72(21):2625-2641. DOI:10.1016/j.jacc.2018.09.042.
• [37]Scarsini R, Kotronias RA, Della Mora F, et al. Angiographyderived index of microcirculatory resistance to define the risk of early discharge in STEMI[J]. Circ Cardiovasc Interv , 2024 , 1 7(3):e013556. DOI:10.1161/CIRCINTERVENTIONS.123.013556.